Clinical Trial Update: Lenalidomide and Paclitaxel in Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of lenalidomide combined with paclitaxel in prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lenalidomide (lenalidomide)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED